Drug Profile
GB 801
Alternative Names: GB-801Latest Information Update: 14 Sep 2023
Price :
$50
*
At a glance
- Originator 1Globe Biomedical
- Class Antineoplastics
- Mechanism of Action Stem cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Sep 2023 Discontinued - Preclinical for Cancer in China (unspecified route) (1Global Biomedical pipeline, September 2023)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Cancer in China
- 05 Aug 2016 Preclinical trials in Cancer in China (unspecified route)